These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 30113291)

  • 41. Systematic review and meta-analysis of the association between peripheral inflammatory cytokines and generalised anxiety disorder.
    Costello H; Gould RL; Abrol E; Howard R
    BMJ Open; 2019 Jul; 9(7):e027925. PubMed ID: 31326932
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Monocyte activation, brain-derived neurotrophic factor (BDNF), and S100B in bipolar offspring: a follow-up study from adolescence into adulthood.
    Mesman E; Hillegers MH; Ambree O; Arolt V; Nolen WA; Drexhage HA
    Bipolar Disord; 2015 Feb; 17(1):39-49. PubMed ID: 25039314
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Decreased plasma levels of brain-derived neurotrophic factor (BDNF) during mixed episodes of bipolar disorder.
    Piccinni A; Veltri A; Costanzo D; Vanelli F; Franceschini C; Moroni I; Domenici L; Origlia N; Marazziti D; Akiskal HS; Dell'Osso L
    J Affect Disord; 2015 Jan; 171():167-70. PubMed ID: 25305432
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Thiobarbituric acid reactive substances (TBARS) is a state biomarker of oxidative stress in bipolar patients in a manic phase.
    Tsai MC; Huang TL
    J Affect Disord; 2015 Mar; 173():22-6. PubMed ID: 25462391
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Peripheral markers of oxidative stress and antioxidative defense in euthymia of bipolar disorder--Gender and obesity effects.
    Bengesser SA; Lackner N; Birner A; Fellendorf FT; Platzer M; Mitteregger A; Unterweger R; Reininghaus B; Mangge H; Wallner-Liebmann SJ; Zelzer S; Fuchs D; McIntyre RS; Kapfhammer HP; Reininghaus EZ
    J Affect Disord; 2015 Feb; 172():367-74. PubMed ID: 25451439
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression.
    Goldsmith DR; Rapaport MH; Miller BJ
    Mol Psychiatry; 2016 Dec; 21(12):1696-1709. PubMed ID: 26903267
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum S100B in manic bipolar disorder patients: Systematic review and meta-analysis.
    da Rosa MI; Simon C; Grande AJ; Barichello T; Oses JP; Quevedo J
    J Affect Disord; 2016 Dec; 206():210-215. PubMed ID: 27475892
    [TBL] [Abstract][Full Text] [Related]  

  • 48. C-reactive protein alterations in bipolar disorder: a meta-analysis.
    Dargél AA; Godin O; Kapczinski F; Kupfer DJ; Leboyer M
    J Clin Psychiatry; 2015 Feb; 76(2):142-50. PubMed ID: 25742201
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multiplex immunoassay analysis of plasma shows differences in biomarkers related to manic or mixed mood states in bipolar disorder patients.
    Haenisch F; Alsaif M; Guest PC; Rahmoune H; Yolken RH; Dickerson F; Bahn S
    J Affect Disord; 2015 Oct; 185():12-6. PubMed ID: 26142689
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A systematic review of evidence for the role of inflammatory biomarkers in bipolar patients.
    Sayana P; Colpo GD; Simões LR; Giridharan VV; Teixeira AL; Quevedo J; Barichello T
    J Psychiatr Res; 2017 Sep; 92():160-182. PubMed ID: 28458141
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Val66Met polymorphism and serum brain-derived neurotrophic factor in bipolar disorder: an open-label trial.
    Grande I; Magalhães PV; Chendo I; Stertz L; Fries GR; Cereser KM; Cunha ÂB; Gói P; Kunz M; Udina M; Martín-Santos R; Frey BN; Vieta E; Kapczinski F
    Acta Psychiatr Scand; 2014 May; 129(5):393-400. PubMed ID: 23957567
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increased plasma levels of brain-derived neurotrophic factor in patients with long-term bipolar disorder.
    Barbosa IG; Huguet RB; Mendonça VA; Neves FS; Reis HJ; Bauer ME; Janka Z; Palotás A; Teixeira AL
    Neurosci Lett; 2010 May; 475(2):95-8. PubMed ID: 20350583
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Indices of insulin resistance and glucotoxicity are not associated with bipolar disorder or major depressive disorder, but are differently associated with inflammatory, oxidative and nitrosative biomarkers.
    Landucci Bonifácio K; Sabbatini Barbosa D; Gastaldello Moreira E; de Farias CC; Higachi L; Camargo AEI; Favaro Soares J; Odebrecht Vargas H; Nunes SOV; Berk M; Dodd S; Maes M
    J Affect Disord; 2017 Nov; 222():185-194. PubMed ID: 28710952
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis.
    Munkholm K; Braüner JV; Kessing LV; Vinberg M
    J Psychiatr Res; 2013 Sep; 47(9):1119-33. PubMed ID: 23768870
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mediator effects of parameters of inflammation and neurogenesis from a N-acetyl cysteine clinical-trial for bipolar depression.
    Panizzutti B; Bortolasci C; Hasebe K; Kidnapillai S; Gray L; Walder K; Berk M; Mohebbi M; Dodd S; Gama C; Magalhães PV; Cotton SM; Kapczinski F; Bush AI; Malhi GS; Dean OM
    Acta Neuropsychiatr; 2018 Dec; 30(6):334-341. PubMed ID: 30008280
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bias in emerging biomarkers for bipolar disorder.
    Carvalho AF; Köhler CA; Fernandes BS; Quevedo J; Miskowiak KW; Brunoni AR; Machado-Vieira R; Maes M; Vieta E; Berk M
    Psychol Med; 2016 Aug; 46(11):2287-97. PubMed ID: 27193198
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Malondialdehyde as a candidate biomarker for bipolar disorder: A meta-analysis.
    Capuzzi E; Ossola P; Caldiroli A; Auxilia AM; Buoli M
    Prog Neuropsychopharmacol Biol Psychiatry; 2022 Mar; 113():110469. PubMed ID: 34740710
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inflammatory markers among adolescents and young adults with bipolar spectrum disorders.
    Goldstein BI; Lotrich F; Axelson DA; Gill MK; Hower H; Goldstein TR; Fan J; Yen S; Diler R; Dickstein D; Strober MA; Iyengar S; Ryan ND; Keller MB; Birmaher B
    J Clin Psychiatry; 2015 Nov; 76(11):1556-63. PubMed ID: 26646032
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Assessment of cytokine levels and hs-CRP in bipolar I disorder before and after treatment.
    Uyanik V; Tuglu C; Gorgulu Y; Kunduracilar H; Uyanik MS
    Psychiatry Res; 2015 Aug; 228(3):386-92. PubMed ID: 26160203
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical Value of Inflammatory and Neurotrophic Biomarkers in Bipolar Disorder: A Systematic Review and Meta-Analysis.
    Vega-Núñez A; Gómez-Sánchez-Lafuente C; Mayoral-Cleries F; Bordallo A; Rodríguez de Fonseca F; Suárez J; Guzmán-Parra J
    Biomedicines; 2022 Jun; 10(6):. PubMed ID: 35740389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.